Jane Street’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
Jane Street's CLYM Position: Q3 2026 in Review
Jane Street increased its Climb Bio (CLYM) stake by 140% in Q3 2026, buying an estimated $2.58M and bringing the position to 316,655 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4198.
Jane Street first reported a position in CLYM in Q3 2024 and has held it in 7 quarters since. 128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- Jane Street held 316,655 shares of Climb Bio worth $3.63M as of Q3 2026.
- Jane Street bought 184,894 Climb Bio shares in Q3 2026, an estimated $2.58M.
- Climb Bio made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4198 holding.
- Jane Street first reported a position in Climb Bio in Q3 2024 and has held it in 7 quarters since.
- 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.